Physicochemical characterization and dissolution study of solid dispersions of furosemide with polyethylene glycol 6000 and polyvinylpyrrolidone k30

Dissolution Technologies

Volumn 15, Issue 3, 2008, Pages 17-25

  Patel, Rakesh P ^a   Patel, Dhaval J ^a   Bhimani, Dipen B ^a   Patel, Jayvadan K ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FUROSEMIDE; MACROGOL 6000; POLYMER; POVIDONE;

AQUEOUS SOLUTION; ARTICLE; COOLING; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; EVAPORATION; INFRARED SPECTROSCOPY; LIQUID; PHYSICAL CHEMISTRY; SOLID; TABLET PROPERTY; WETTABILITY; X RAY DIFFRACTION;

EID: 77955814276     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT150308P17     Document Type: Article

References (30)

1. Habib, F. S.; Attia, M. A. Effect of particle size on the dissolution rate of monophenylbutazone solid dispersion in presence of certain additives. Drug Dev. Ind. Pharm. 1985, 11, 2009-2019.
2. Chow, A. H. L.; Hsia, C. K.; Gordon, J. D.; Young, J. W. M.; Vargha-Butler, E. I. Assessment of wettability and its relationship to the intrinsic dissolution rate of doped phenytoin crystals. Int. J. Pharm. 1995, 126, 21-28.
3. Flego, C.; Lovrecich, M.; Rubessa, F. Dissolution rate of griseofulvin from solid dispersion with poly(vinylmethylether: maleic anhydride). Drug Dev. Ind. Pharm. 1988, 14, 1185-1202.
4. Pitha, J. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients. J. Pharm. Sci. 1985, 74, 987-990.
5. Sekiguchi, K.; Kanke, M.; Tsuda, Y.; Ishida, K.; Tsuda, T. Dissolution behavior of solid drugs. III. Determination of the transition temperature between the hydrate and anhydrous forms of phenobarbital by measuring their dissolution rates. Chem. Pharm. Bull. 1973, 21, 1592-1600.
6. Chiou, W. L.; Riegelman, S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 1971, 60, 1281-1302.
7. Sheu, M. T.; Yeh, C. M.; Sokoloski, T. D. Characterization and dissolution of fenofibrate solid dispersion systems. Int. J. Pharm. 1994, 103, 137-146.
8. Craig, D. Q. M. The mechanism of drug release from solid dispersion in water-soluble polymers. Int. J. Pharm. 2002, 231, 131-144.
9. Otsuka, M.; Onone, M.; Matsuda, Y. Hygroscopic stability and dissolution properties of spray-dried solid dispersion of furosemide with Eudragit. J. Pharm. Sci. 1996, 82, 32-38.
10. Leuner, C; Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50, 47-60.
11. Van den Mooter, G.; Augustijns, P.; Blaton, N.; Kinget, R. Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int. J. Pharm. 1998, 164, 67-80.
12. Susumu, H.; Takeshi, H.; Naho, F.; Akira, K.; Etsuo, Y.; Katsuhide, T. Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int. J. Pharm. 2005, 302, 103-112.
13. Teresa, M. M.; Victoria, M. M.; Gloria, E. S. Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone. Il Farmaco. 2002, 57, 723-727.
14. Franco, M.; Trapani, G.; Latrofa, A.; Tullio, C.; Provenzano, M. R.; Serra, M.; Muggironi, M.; Biggio, G.; Liso, G. Dissolution properties and anticonvulsant activity of phenytoin-polyethylene glycol 6000 and -polyvinylpyrrolidone K-30 solid dispersions. Int. J. Pharm. 2001, 225, 63-73.
15. Melgardt, M. V.; Dale, E. W.; Jakkie, G.; Amol, K. X-Ray powder diffraction determination of the relative amount of crystalline acetaminophen in solid dispersions with PVP. Int. J. Pharm. 1998, 163, 219-224.
16. Arias, M. J.; Moyano, J. R.; Gines, J. M. Study by DSC and HSM of the oxazepam PEG 6000 and oxazepam-D-mannitol systems: Application to the preparation of solid dispersions. Thermochim. Acta 1998, 321, 33-41.
17. Abdulrahman, M. A.; Fahad, J. A.; Khalid, A. M. A.; Mohammad, S. M. Analytical Profile of Furosemide. In Analytical Profiles of Drug Substances; Florey, K., Ed.; Academic Press: London, 1989; Vol. 18, pp 153-193.
18. Higuchi, T.; Connors, K. Phase-solubility techniques. Adv. Anal. Chem. Instrum. 1965, 4, 117-123.
19. Leuner, C.; Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000, 50, 47-60.
20. Frances, C.; Veiga, M. D.; Espanol, O. M.; Cadorniga, R. Preparation, characterization and dissolution of ciprofloxacin/PEG 6000 binary systems. Int. J. Pharm. 1991, 77, 193-198.
21. Patel, R. P.; Patel, M. M. Solid-state characterization and dissolution properties of lovastatin hydroxypropyl-β-cyclodextrin inclusion complex. Pharm. Technol. 2007, 2, 72-82.
22. Moore, J. W.; Flanner, H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 20, 64-74.
23. Reppas, C.; Nicolaides, E. Analysis of Drug Dissolution Data. In Oral Drug Absorption Prediction and Assessment; Dressman, J. B., Lennernäs, H., Eds.; Marcel Dekker: New York, 2000, pp 229-254.
24. Vueba, M. L.; Batista de Carvalho, L. A. E.; Veiga, F.; Sousa, J. J.; Pina, M. E. Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets. Eur. J. Pharm. Biopharm. 2004, 58, 51-59.
25. Chengsheng, L.; Kashappa, H. D. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Dev. Ind. Pharm. 2005, 1, 1-10.
26. Spamera, E.; Müller, D. G.; Wesselsb, P. L.; Ventera, J. P. Characterization of the complexes of furosemide with 2-hydroxypropyl-β-cyclodextrin and sulfobutyl ether-7-β-cyclodextrin. Eur. J. Pharm. Sci. 2002, 16, 247-253.
27. Horter, D.; Dressman, J. B. Influence of physiochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Del. Rev. 1997, 25, 3-14.
28. Galia, E.; Horton, J.; Dressman, J. B. Albendazole generics-a comparative in vitro study. Pharm. Res. 1999, 16, 1871-1875.
29. Noory, C.; Tran, N.; Ouderkirk, L.; Brown, S.; Perry, J.; Lopez, J.; Colon, M.; Faberlle, M. Rethinking the use of water as a dissolution medium. Dissolution Technol. 1999, 6 (4), 6-7.
30. Pharmaceutical Technology. In Pharmaceutics: The Science of Dosage Form Design; Aulton, M. E., Ed.; Churchill Livingstone: London, 1988; pp 600-616.